There have been so many multi-cancer early detection tests coming on the market and the users are generally not aware of them – each of them have a different capability and strengths.
Genomeweb had done a survey of what are the tests available and how they are perceived. Look at the survey at : https://www.genomeweb.com/cancer/genomeweb-survey-enthusiasm-mced-tests-research-and-clinical-care-despite-evidence-caveats
To adopt this most participants asked for more data.
One point to note is the barriers to adoption of these tests mention – lack of established diagnostic confirmatory protocols for doctors to pursue, false positives and lack of data for mortality benefit but not much in terms of cost.
